Versiti Blood Center, Inc.: Single Audit Reports and Findings

Versiti Blood Center, Inc.'s most recent single audit in the Federal Audit Clearinghouse covers fiscal year 2025, accepted May 26, 2026; the auditor observed on that filing is Grant Thornton LLP. It reported no findings. 10 filings from 2016 to 2025 are on record. Data as of 2026-11-06.

Data as of Nov 6, 2026 · Source: Federal Audit Clearinghouse (public data)

Single audits by year

One row per audit year as the Federal Audit Clearinghouse accepted it. The auditor named is the one observed on that filing; Versiti Blood Center, Inc. is recorded in MILWAUKEE, Wisconsin under EIN 390807235, and the Clearinghouse records it as a nonprofit. Each report opens on the Clearinghouse itself; how to search the Federal Audit Clearinghouse explains the rest of the reporting package.

Single audits filed by Versiti Blood Center, Inc.
Audit yearFiscal year endFederal expendedThreshold appliedAuditor observedOpinionFindingsMW / SDFAC report
20252025-12-31$23,421,732$1,000,000Grant Thornton LLPUnmodified0—2025-12-GSAFAC-0000410536
20242024-12-31$22,588,850$750,000Grant Thornton LLPUnmodified0—2024-12-GSAFAC-0000371170
20232023-12-31$21,335,992$750,000Grant Thornton LLPUnmodified0—2023-12-GSAFAC-0000042387
20222022-12-31$21,204,512$750,000Grant Thornton LLPUnmodified0—2022-12-CENSUS-0000058725
20212021-12-31$18,184,597$750,000Grant Thornton LLPUnmodified0—2021-12-CENSUS-0000058725
20202020-12-31$13,796,525$750,000Grant Thornton LLPUnmodified0—2020-12-CENSUS-0000058725
20192019-12-31$13,676,077$750,000Grant Thornton LLPUnmodified0—2019-12-CENSUS-0000058725
20182018-12-31$13,069,739$750,000Grant Thornton LLPUnmodified0—2018-12-CENSUS-0000058725
20172017-12-31$12,521,591$750,000Grant Thornton LLPUnmodified0—2017-12-CENSUS-0000058725
20162016-12-31$11,842,122$750,000Grant Thornton LLPUnmodified0—2016-12-CENSUS-0000058725

When is the next single audit due?

If Versiti Blood Center, Inc. is again required to have a single audit for the fiscal year ending Dec 31, 2026, the reporting package is due to the Federal Audit Clearinghouse by Sep 30, 2027 at the latest.

Whether an audit is required depends on federal awards expended in that year (the single audit threshold). The rule, 2 CFR 200.512(a): the reporting package is due within 30 calendar days after the auditee receives the auditor's report or nine months after the end of the audit period, whichever is earlier; the date above is the nine-month date, moved to Monday when it falls on a weekend. Last verified: 2026-11-15.

Which federal programs did this organization report?

From the most recent accepted report, as listed on its schedule of expenditures of federal awards (SEFA). "Major" is the designation the auditor made under 2 CFR 200.518, not ours.

Federal programs on the most recent report
ALNProgramExpendedMajor
93.839BLOOD DISEASES AND RESOURCES RESEARCH$13,268,106Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$1,217,355Yes
12.RDEvaluating the Safety and Ease of Use of CounterFlow Hemostatic Gauze for Extreme Cold Environments$1,123,173Yes
93.RDRetrovirus Epidemiology Donor Study IV$795,036Yes
93.859ALLERGY AND INFECTIOUS DISEASES RESEARCH$675,991Yes
93.395CANCER TREATMENT RESEARCH$657,754Yes
93.310TRANS-NIH RESEARCH SUPPORT$635,863Yes
12.420MILITARY MEDICAL RESEARCH AND DEVELOPMENT$591,354Yes
93.396CANCER BIOLOGY RESEARCH$485,255Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$424,895Yes
93.35321ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT$335,694Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$314,126Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$256,779Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$227,482Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$222,464Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$212,886Yes
93.855ALLERGY AND INFECTIOUS DISEASES RESEARCH$198,486Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$162,618Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$131,792Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$128,980Yes
93.RDBARDA: CERUS - Development and Implementation of Pathogen Reduction Technology$123,579Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$113,271Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$108,151Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$93,701Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$88,109Yes

What findings did the auditor report?

The reference is the auditor’s; the requirement is the Compliance Supplement category the auditor selected. The finding text itself is not reproduced here; the FAC report linked above carries it in full. What the two severity levels mean: material weakness vs significant deficiency.

The most recent report lists no finding.

Form 990 and IRS registration

Form 990 "accounting fees" (Part IX line 11c) cover all accounting services reported by the organization and are not the price of an audit engagement.

Where to find the return itself, and what our Form 990 data covers: Form 990 lookup.

Most recent return
990 for 2024-12
Total revenue
$281,020,247
Total assets
$213,041,862
Accounting fees (Part IX line 11c)
$83,827
Paid preparer
GRANT THORNTON ADVISORS LLC
IRS object id
202513159349304706
NTEE code
E610
Exempt under
501(c)(3)
Ruling year
1994
BMF release
2026-10-20

Read next

How we computed this

Every row comes from the Federal Audit Clearinghouse record named beside it, one report per audit year, with a resubmission superseding the filing it replaces. The auditor is the one named on that filing — it is not a statement about who audits Versiti Blood Center, Inc. now. Form 990 figures come from the IRS e-filed return named by its object id. This page exists because the organization filed at least two single audits, or one with a finding.

Cite this page

AuditRadar. “Versiti Blood Center, Inc., Wisconsin Single Audit FY2025.” https://getauditradar.com/single-audits/wi/versiti-blood-center-inc-390807235/. Data as of 2026-11-06.